Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 — PRINCIPLE Trial

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. — Read on http://www.principletrial.org/news/asthma-drug-budesonide-shortens-recovery-time-in-non-hospitalised-patients-with-covid-19/

Your Migraine Cocktail Didn’t Work? Shake it Up! — Taming the SRU

Acute migraine causes 1.2 million visits to the US emergency departments annually. Headache is the fifth leading cause of patients presenting to the emergency department (ED) in the United States. [3] We have previously discussed evidence behind the traditional ‘Migraine Cocktail’ here. In this post, we will address adjunctive therapies when the first-line treatments haven’t… Your…